San Diego VC, OrbiMed make competing buyout offers for struggling Theseus


A San Diego investment firm known for buying struggling biotechs only to shut them down is competing with OrbiMed for a local company that's on its last legs.

Previous QTS Data Centers commits to $4.4B investment in New Albany
Next Apartment developer pays $21 million for Westshore office park land